- Home
- MRK vs MVSTW Comparison
MRK vs MVSTW Comparison
Compare MRK & MVSTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRK | MVSTW |
|---|---|---|
| Founded | 2000 | 2006 |
| Country | United States | United States |
| Employees | N/A | 1921 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | N/A |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRK | MVSTW |
|---|---|---|
| Price | $115.85 | $0.05 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $124.29 | N/A |
| AVG Volume (30 Days) | ★ 8.0M | 97.2K |
| Earning Date | 05-05-2026 | 03-14-2025 |
| Dividend Yield | ★ 2.93% | N/A |
| EPS Growth | ★ 8.01 | N/A |
| EPS | ★ 7.28 | N/A |
| Revenue | ★ $65,011,000,000.00 | $370,989,000.00 |
| Revenue This Year | $3.74 | N/A |
| Revenue Next Year | $5.47 | N/A |
| P/E Ratio | $15.94 | ★ N/A |
| Revenue Growth | 1.31 | ★ 39.03 |
| 52 Week Low | $75.40 | $0.03 |
| 52 Week High | $125.14 | $0.65 |
Technical Indicators
Market Signals| Indicator | MRK | MVSTW |
|---|---|---|
| Relative Strength Index (RSI) | 45.57 | 44.36 |
| Support Level | $113.82 | $0.03 |
| Resistance Level | $125.14 | $0.07 |
| Average True Range (ATR) | 2.78 | 0.01 |
| MACD | -1.04 | 0.00 |
| Stochastic Oscillator | 18.37 | 45.63 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About MVSTW Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.